enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Acute severe asthma - Wikipedia

   en.wikipedia.org/wiki/Acute_severe_asthma

   Acute severe asthma, also known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators (inhalers) and corticosteroids. [2] Asthma is caused by multiple genes , some having protective effect, with each gene having its own tendency to be influenced by the environment although a ...

3. Anti-asthmatic agents - Wikipedia

   en.wikipedia.org/wiki/Anti-asthma_agents

   Anti-asthmatic agents, also known as anti-asthma drugs, refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both.

4. If You're Living With Asthma, Here's Every Single Treatment ...

   www.aol.com/youre-living-asthma-heres-every...

   Dr. Bowser agrees, adding that other OTC asthma treatments, like Primatene Mist, have side effects of increasing your heart rate while symptom relief is short-lived. ... Related: 10 Severe Allergy ...

5. First new asthma attack treatment in 50 years - AOL

   www.aol.com/news/first-asthma-attack-treatment...

   Researchers say they have found the first new treatment for asthma attacks in 50 years. The injection dampens part of the immune system that can go into overdrive in flare-ups of both asthma and a ...

6. Asthma - Wikipedia

   en.wikipedia.org/wiki/Asthma

   Magnesium sulfate intravenous treatment increases bronchodilation when used in addition to other treatment in moderate severe acute asthma attacks. [ 17 ] [ 240 ] [ 241 ] In adults intravenous treatment results in a reduction of hospital admissions. [ 242 ]

7. GSK's experimental drug shows promise in reducing severe ...

   www.aol.com/news/gsks-experimental-drug-shows...

   (Reuters) -GSK's experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to make peak ...